News

Pulmatrix announced its entry into a Binding Term Sheet with Cipla Technologies LLC, a subsidiary of Cipla Limited for the co-development and commercialization of Pulmazole (PUR1900) –…
Read More...

Novartis announced that it is adding to its broad portfolio of immunomodulatory medicines with the planned acquisition of IFM Tre, a subsidiary of IFM Therapeutics LLC focused on…
Read More...

AstraZeneca and MSD, Inc., Kenilworth, NJ, US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced that the US Food and Drug Administration (FDA) has granted…
Read More...

Amneal Pharmaceuticals announced that it has entered into an agreement with Zentiva Group a.s., under which Zentiva has acquired Creo Pharmaceuticals Ltd., a subsidiary of Amneal that…
Read More...

Puma Biotechnology and Pierre Fabre have entered into an exclusive license agreement under which Pierre Fabre will develop and commercialize NERLYNX (neratinib) within Europe and part…
Read More...

ProteoNic Biotechnology BV announced that it has licensed its 2G UNic technology for boosting recombinant protein production to the pharmaceutical company Bayer. Under the agreement,…
Read More...

Gilead Sciences announced HepConnect, a five-year, multi-million dollar initiative aimed at addressing the sharp increase in chronic hepatitis C (HCV) infections fueled by the nation’s…
Read More...

AstraZeneca has entered into a global development and commercialisation collaboration agreement with Daiichi Sankyo Company, Limited (Daiichi Sankyo) for trastuzumab deruxtecan…
Read More...

Barc Lab and OWL Metabolomics announced that they have entered into a global strategic partnership combining Barc Lab's industry leading central lab services with OWL Metabolomics'…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Mayzent (siponimod) for the treatment of adults with relapsing forms of multiple sclerosis, including…
Read More...

Clarus Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved JATENZO (testosterone undecanoate capsules for oral use) (CIII) for testosterone replacement…
Read More...

OcellO B.V., a Contract Research Organisation offering 3D cell based assay services for drug discovery to the pharmaceutical industry, announced that it entered an agreement to provide…
Read More...

Velicept Therapeutics announced that its next generation beta-3 adrenoceptor agonist solabegron met the primary endpoint in VEL-2002, a Phase 2b study in patients with overactive…
Read More...

StrideBio announced the signing of a collaboration and license agreement with Takeda Pharmaceutical Company Limited (Takeda) to develop in vivo AAV based therapies for Friedreich's…
Read More...

Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P., in conjunction with Mundipharma EDO GmbH, announced that the U.S.…
Read More...

Elicio Therapeutics, a next generation immuno-oncology company, engineering therapies for cancer killing immune responses, launched and announced the appointment of Robert Connelly as…
Read More...

OWC Pharmaceutical Research Corp., the company transforming cannabis into scientifically proven and clinically approved medical solutions, announces an agreement with the Tel Aviv…
Read More...

Cook Regentec announced the launch of the ProFusion Therapeutic Infusion Needle used for intramuscular or subdermal infusion of therapeutic agents. The device is now available in the…
Read More...

BioInvent International AB, a biotech company focused on the discovery and development of novel immuno-regulatory antibodies to treat cancer and Transgene, a biotech company that…
Read More...

Vect-Horus S.A.S. (Marseille, France) announced that Vect-Horus and Ono Pharmaceutical Co., Ltd. (Osaka, Japan) signed a collaboration and license agreement, focused on the development…
Read More...